​
​

Vivani Medical Stock (NASDAQ:VANI)

RevenueFinancialsChart
Vivani Medical by TradingView

Previous Close

$1.33

52W Range

$0.84 - $7.80

50D Avg

$1.24

200D Avg

$1.49

Market Cap

$79.37M

Avg Vol (3M)

$96.08K

Beta

3.52

Div Yield

-

VANI Company Profile

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

36

IPO Date

Nov 19, 2014

Website

VANI Performance

VANI Financial Summary

Dec 23Dec 22Dec 21
Revenue---
Operating Income---
Net Income---
EBITDA---
Basic EPS---
Diluted EPS---

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q4 19Mar 19, 20 | 5:00 PM
Q3 19Nov 15, 19 | 5:00 PM
Q2 19Aug 07, 19 | 5:00 PM

Peer Comparison

TickerCompany
PMVPPMV Pharmaceuticals, Inc.
TYRATyra Biosciences, Inc.
RLYBRallybio Corporation
TRDAEntrada Therapeutics, Inc.
ANTXAN2 Therapeutics, Inc.
HCWBHCW Biologics Inc.
PHVSPharvaris N.V.
PEPGPepGen Inc.
ANEBAnebulo Pharmaceuticals, Inc.
ELYMEliem Therapeutics, Inc.